Skip to Main Content

Paper Details

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.
Ann Oncol
1
2019
HER2, doxorubicin, paclitaxel, trastuzumab

Datasets

Release 1.2